0001179110-18-002111.txt : 20180214
0001179110-18-002111.hdr.sgml : 20180214
20180214181108
ACCESSION NUMBER: 0001179110-18-002111
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20180212
FILED AS OF DATE: 20180214
DATE AS OF CHANGE: 20180214
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Kaundinya Ganesh Venkataraman
CENTRAL INDEX KEY: 0001294284
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-50797
FILM NUMBER: 18614862
MAIL ADDRESS:
STREET 1: C/O MOMENTA PHARMACEUTICALS, INC.
STREET 2: 675 WEST KENDALL STREET
CITY: CAMBRIDGE
STATE: MA
ZIP: 02142
FORMER NAME:
FORMER CONFORMED NAME: Venkataraman Ganesh
DATE OF NAME CHANGE: 20040618
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: MOMENTA PHARMACEUTICALS INC
CENTRAL INDEX KEY: 0001235010
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 043561634
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 675 WEST KENDALL STREET
CITY: CAMBRIDGE
STATE: MA
ZIP: 02142
BUSINESS PHONE: 617 491-9700
MAIL ADDRESS:
STREET 1: 675 WEST KENDALL STREET
CITY: CAMBRIDGE
STATE: MA
ZIP: 02142
4
1
edgar.xml
FORM 4 -
X0306
4
2018-02-12
0
0001235010
MOMENTA PHARMACEUTICALS INC
MNTA
0001294284
Kaundinya Ganesh Venkataraman
C/O MOMENTA PHARMACEUTICALS, INC.
675 WEST KENDALL STREET
CAMBRIDGE
MA
02142
0
1
0
0
COO & CSO
Common Stock
2018-02-12
4
M
0
10103
7.41
A
501031
D
Common Stock
2018-02-12
4
S
0
341
16.20
D
500690
D
Common Stock
2018-02-14
4
S
0
4645
15.16
D
496045
D
Restricted Stock Units
2018-02-12
4
A
0
50000
0
D
Common Stock
50000
50000
D
Stock Option (Right to Buy)
7.41
2018-02-12
4
M
0
10103
7.41
A
2012-02-22
2018-02-22
Common Stock
10103
0
D
This transaction was effected pursuant to a Rule 10b5-1 trading plan.
Each Restricted Stock Unit represents a contingent right to receive one share of MNTA common stock.
Subject to certain criteria, the restricted stock units will vest with respect to 50% of the shares on the first anniversary of the grant date, and the remaining 50% will vest on the second anniversary of the grant date.
/s/ Marie T. Washburn as attorney in fact
2018-02-14